By Susan Kreimer | May 16, 2024 | Read this story at NeurologyToday Article In Brief In the ENRICH trial, patients with an acute intracerebral hemorrhage who underwent a minimally invasive hematoma had better scores on the modified Rankin Scale at 180 days compared with those who received standard medical management. The study is the […]
Viz.ai and NICO Corporation Announce Collaboration to Improve Outcomes in Patients with Intracerebral Hemorrhage
April 17, 2024 | Read this story at Viz.ai Viz.ai and NICO Corporation Announce Collaboration to Improve Outcomes in Patients with Intracerebral Hemorrhage Data from NICO’s ENRICH trial, published in The New England Journal of Medicine, demonstrates functional improvement for minimally-invasive parafascicular surgery (MIPS) SAN FRANCISCO – April 17, 2024 – Viz.ai, the leader in […]
NEJM QUICK TAKE: Early Minimally Invasive Removal of Intracerebral Hemorrhage
DOI: 10.1056/NEJMdo007458 | April 10, 2024 | Read this story at New England Journal of Medicine Whether early minimally invasive surgical removal of an intracerebral hemorrhage improves functional outcomes is unknown. New research findings are summarized in a short video. You will need to sign in to nejm.org to watch the video.
Surgical Clot Removal Superior to Meds Alone in ICH: ENRICH Published
By Patrice Wendling | April 10, 2024 | Read this story at Medscape The ENRICH trial, showing improved functional outcomes with surgical clot evacuation plus medical management, has now been published in The New England Journal of Medicine. The trial results were first presented at the American Association of Neurological Surgeons (AANS) 2023 Annual Meeting, […]
NICO’s Minimally Invasive Evacuation Technology Outperforms Guideline-Based Medical Management as Intracerebral Hemorrhage Treatment
By Marco Meglio | April 11, 2024 | Read this story at NeurologyLive At 180 days after surgery, weighted disability scores were better with surgery plus medical management than with medical management alone. Investigators have published the full dataset of the pivotal ENRICH trial (NCT02880878), the first positive trial to show improved functional […]
The New England Journal of Medicine Publishes Complete Data from ENRICH, the First Positive Trial to Improve Functional and Economic Outcomes for Intracerebral Hemorrhage (ICH)
April 11, 2024 | Read this story at Biospace Data Shows Surgery with NICO’s Technology is Superior to Standard of Care, Reduces Mortality, and Significantly Decreases Time in Hospital ICH is the Deadliest, Most Costly, and Most Disabling Form of Stroke INDIANAPOLIS, April 11, 2024 /PRNewswire/ — NICO Corporation, a pioneer and […]
The Journey to Establishing the World’s First Successful Surgical Treatment for Hemorrhagic Stroke
The Journey to Establishing the World’s First Successful Surgical Treatment for Hemorrhagic Stroke By Jim Pearson, President & CEO, NICO Corporation | October 31, 2023 | Read this story at Medical Device News Magazine Strokes are a leading cause of death and disability worldwide, with rates of stroke continuing to increase even in younger adults.1 […]
New Technology in Treating Hemorrhagic Stroke: Is a New Gold Standard on the Horizon?
MEDICAL DEVICE NEWS MAGAZINE THE GO-TO-MAGAZINE FOR THE PRACTICING MEDICAL SPECIALIST May 10, 2017 by Larry Dickinson, MD There is an unmet need in the United States and abroad for the treatment of hemorrhagic stroke. But now, this deadliest, costliest and most debilitating form of stroke with no surgical standard is experiencing a paradigm shift. […]